Results 151 to 160 of about 30,982 (215)

Evaluating COVID-19 vaccine effectiveness across epidemiologic designs: test-negative case-control versus retrospective cohort analyses in a nationwide study. [PDF]

Int J Epidemiol
Sukik L, Paul P, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Thani AAA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Chemaitelly H, Abu-Raddad LJ.   +22 more
europepmc   +1 more source

Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States. [PDF]

Infect Dis Ther
Vicic N, Bogdanov A, Hensler H, Ryan T, Zeng N, Beck E, Patry E, Bonafede M, Araujo AB, Wilson A.   +9 more
europepmc   +1 more source

Comparator-Dependent Safety Signals for Incident Systemic Autoimmune Rheumatic Diseases After mRNA COVID-19 Vaccination: A Systematic Review. [PDF]

Vaccines (Basel)
Pinte L, Balanescu P, Dima A, Mandescu AM, Simion-Stanciu ME, Dumitru AC, Baicus C.   +6 more
europepmc   +1 more source

Recoding by N¹-methylpseudouridine guides rational mRNA vaccine design. [PDF]

Nat Commun
Poulis P, Robecchi G, Kurochkina AO, Felletti M, Rodnina MV.   +4 more
europepmc   +1 more source

Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh. [PDF]

Vaccines (Basel)
Akhtar M, Islam MR, Khan ZH, Akter A, Tauheed I, Ahmed T, Khan II, Amin MA, Khaton F, Khanam F, Islam MT, Biswas PK, Rashid R, Rashid MM, Hossain MZ, Alam AN, Alamgir ASM, Ryan ET, Banu S, Shirin T, Chowdhury F, Khan AI, Bhuiyan TR, Qadri F.   +23 more
europepmc   +1 more source

Sex differences in the long-term tolerability of BNT162b2 in children and adolescents. [PDF]

Mol Cell Pediatr
Moor J, Grieshaber V, Toepfner N, Holzwarth S, Moor MB, Kublickiene K, Strumann C, Chao CM.   +7 more
europepmc   +1 more source

Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review. [PDF]

Infect Dis Ther
Thoburn E, Giannakoulis VG, Hu T, Goebe H, Raina S, Moran MM, Perreault B, Val-Maranes L, Millar EB, Whittle I, Pearson F, Lopez SMC.   +11 more
europepmc   +1 more source

Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS-CoV-2 Vaccination: A Systematic Review. [PDF]

J Skin Cancer
Mussi M, Zengarini C, Corrà A, Brunetti T, Natale A, La Placa M, Piraccini BM, Guglielmo A, Pileri A.   +8 more
europepmc   +1 more source

Hybrid immunity following SARS-CoV-2 infection and vaccination is associated with more sustained antibody levels, and lower reinfection risk. [PDF]

Sci Rep
Che-Kamaruddin N, Johari J, Yahaya H, Zainal N, Nguyen H, Hontz RD, Letizia AG, AbuBakar S.   +7 more
europepmc   +1 more source

BNT162b2 LP.8.1 early vaccine effectiveness against COVID-19 emergency department, urgent care, and outpatient visits. [PDF]

Nat Commun
Appaneal HJ, Lopes VV, Nguyen JL, Volkman HR, Zasowski EJ, Caffrey AR.   +5 more
europepmc   +1 more source